Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-462,000
Closed -$12M 4804
2023
Q4
$12M Buy
462,000
+260,300
+129% +$5.94M 0.01% 1240
2023
Q3
$4.65M Sell
201,700
-245,100
-55% -$6.14M ﹤0.01% 1872
2023
Q2
$10.5M Buy
446,800
+10,000
+2% +$170K 0.01% 1304
2023
Q1
$5.18M Buy
+436,800
New +$6.22M 0.01% 1911
2022
Q1
Sell
-7,048
Closed -$203K 5996
2021
Q4
$203K Hold
7,048
﹤0.01% 4874
2021
Q3
$283K Buy
+7,048
New +$315K ﹤0.01% 4394

Other funds holding XP

D.E. Shaw & Co's XP Position: Q1 2026 in Review

D.E. Shaw & Co reduced its XP (XP) stake by 64% in Q1 2026, selling an estimated $3.69M and leaving 105,532 shares worth $2.01M. The position accounts for ﹤0.01% of the portfolio, ranked #2907.

D.E. Shaw & Co first reported a position in XP in Q1 2020 and has held it in 13 quarters since. The position peaked at $92M in Q4 2023. 356 funds tracked by Wall St. Rank hold XP as of Q1 2026.

  • D.E. Shaw & Co held 105,532 shares of XP worth $2.01M as of Q1 2026.
  • D.E. Shaw & Co sold 190,959 XP shares in Q1 2026, an estimated $3.69M.
  • XP made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2907 holding.
  • D.E. Shaw & Co first reported a position in XP in Q1 2020 and has held it in 13 quarters since.
  • D.E. Shaw & Co's XP position peaked at $92M in Q4 2023.
  • 356 funds tracked by Wall St. Rank held XP as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.